(Q33809566)

29 July 2017

1 reference

title

Treatment of patients with chronic hepatitis C and normal ALT levels (English)

1 reference

29 July 2017

1 reference

1 reference

Tassopoulos NC

1

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

published in

Journal of Hepatology

1 reference

29 July 2017

volume

31 Suppl 1

1 reference

29 July 2017

page(s)

193-196

1 reference

Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980400-0

7 January 2021

Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980400-0

7 January 2021

High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980400-0

7 January 2021

Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980400-0

7 January 2021

Epidemiology of Hepatitis C in the West

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980400-0

7 January 2021

Therapy of hepatitis C: patients with normal aminotransferase levels

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980400-0

7 January 2021

Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980400-0

7 January 2021

Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980400-0

7 January 2021

Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980400-0

7 January 2021

Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980400-0

7 January 2021

Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980400-0

7 January 2021

The interferons. Mechanisms of action and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980400-0

7 January 2021

10.1016/S0168-8278(99)80400-0

Identifiers

DOI

1 reference

29 July 2017

1 reference